| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac3e787a6871df4284213bb52de1883d |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2005-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c12ec1c4c9031de0e1644919b4788cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3229c0a7cd278640b795e6664dbe7d0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ac29233365c417338ee743d2c8f5f89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b9687b6d295c1df690d5e0fe5e2273e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d18f370db6e399266d843eb8d17e440f |
| publicationDate |
2007-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-PA05003413-A |
| titleOfInvention |
USE OF PEPTIDE GK-1 FOR POTENTIAL THE IMMUNE RESPONSE GENERATED BY THE INFLUENZA VACCINE. |
| abstract |
This invention consists in the use of the peptide called GK-1 characterized by the sequence GYYPSDPNTFYAPPYSA to prepare a medicament that potentiates the protective immunological response of various vaccine antigens when used in conjunction with these antigens, achieving an increase in the amount of specific antibodies against serum vaccine antigens, resulting in an enhancement of the immune response of organisms with a faster decrease in viral titers. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013015668-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11020449-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9446122-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3459557-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017200369-A3 |
| priorityDate |
2005-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |